Erstellt von fchar99
Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Corp.
WKN: 936853 / Symbol: EW / Name: Edwards Lifesciences / Aktie / Ausrüstung & Versorgung / Large Cap /
79,84 €
-1,61 %
Verkaufen Sie diese Aktie
Schauen Sie sich die Grafik an, die seit Juli stetig abgenommen hat.
(Zielkurs erreicht)
Buy Edwards Lifesciences Corp.
Buy Edwards Lifesciences Corp.
Buy Edwards Lifesciences Corp.
Edwards Lifesciences Co. (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $102.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Jefferies Financial Group Inc. from $103.00 to $107.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $96.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $96.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $90.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Citigroup Inc. from $110.00 to $94.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Citigroup Inc. from $94.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Royal Bank of Canada from $86.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Truist Financial Co. from $83.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Mizuho from $90.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating. They now have a $57.00 price target on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Morgan Stanley from $102.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Truist Financial Co. from $76.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Truist Financial Co. from $78.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat
Neueste Beiträge
TD_Cowen in Booz Allen Hamilton A diskutieren